Alphatec Holdings had its Relative Strength (RS) Rating upgraded from 90 to 93 Thursday.
Looking For The Best Stocks To Buy And Watch? Start Here
This proprietary rating measures technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the last 52 weeks matches up against other publicly traded companies.
Over 100 years of market history shows that the stocks that go on to make the biggest gains typically have an 80 or better RS Rating in the early stages of their moves.
Alphatec Holdings is working on a cup without handle with a 12.79 buy point. See if it can clear the breakout price in volume at least 40% higher than normal.
Alphatec Holdings showed 0% earnings growth in its most recent report. Revenue rose 28%. The next quarterly numbers are expected on or around May 1.
Alphatec Holdings earns the No. 21 rank among its peers in the Medical-Products industry group. Pro-Dex, Boston Scientific and Penumbra are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
